Thursday, May 3, 2012

The ones that clone in our country " The precious gene " Obtain the patent for invention of U.S.A. for the first time

The ones that clone in our country " The precious gene " Obtain the patent for invention of U.S.A. for the first time
The ones that clone in our country " The precious gene " Obtain the patent for invention of U.S.A. for the first time
It is reported ' The red reporter of reporter and king Zhang Guoqing) A few days ago, 307 hospital immune chief of the office Professor Xi YongZhies of PLA man led the scarce " precious gene " that the group succeeded in cloning --Chicken's II type collagenic CCOL2A1 total length cDNA of the code, obtain the genetic patent for invention in U.S.A., therefore become the internationally acknowledged first American genetic patent for invention with great medical value that our country obtains up until now. At the same time, also indicate the scientist of our country can utilize this gene independently, further develop gene serious category medicine, target gene and therapeutic genetic vaccine of gene therapy,etc. new therapeutic method of treating rheumatoid and arthritis effectively. It is reported, Xi YongZhi has already received the official document notice of the national patent and trademark office of U.S.A. recently, determine to award it the American genetic patent for invention formally, approve all right and a requirement in this application for a patent for invention. It is introduced, since the latter stage in the 1990s last century, Xi YongZhi led the group to begin to explore that induce the immunity to tolerate and treat this world great difficult problem of rheumatoid and arthritis. They focus sight on cloning on chicken's II type collagenic CCOL2A1 total length cDNA and genome DNA the question of this focus of the code at first, because clone and get this important cDNA at first only in the world, and declare the genetic patent for invention with totally independent intellectual property right, especially the United States and Japan, Europe " The tripartite patent " (Note: " tripartite patent " Mean that has all filed an application and have already been invented the same patent for invention of the patent right in the American patent and trademark office in European patent office and Japanese patent office) ,It should be scarce to go on " The precious gene " Development and utilization of relevant genomic medicine, genetic vaccine, gene therapy,etc.. Xi YongZhi introduces, this genetic patent for invention in U.S.A. has already had " tripartite patent " of the international standard Advantage. At present, this seminar is in the national natural fund key subject and " eleven five " " great new medicine innovates " in the country Under the subsidy of the great project of science and technology, have already adopted this scarce " precious gene " Take the lead in, succeed in developing in the world first because of different kinds of CCOL2A1 original, can wind of treating etc. warm arthritis all new getting therapeutic genetic vaccine effectively. At present, the relevant research before the seminar is improving new medicine actively clinically.


|

No comments:

Post a Comment